Introduction
Both kidney dysfunction and cognitive impairment are common problems in elderly people which have severe consequences, such as diminished quality of life, higher mortality rate, and increased use of health services [1, 2] . Currently, 10% of the world's population is aged over 60, and the very old people, aged over 80, are the fastest growing group of older people today [3] . The ageing of population along with the growing global prevalence of hypertension has also led to a corresponding worldwide increase in the prevalence of chronic kidney disease (CKD) and cognitive impairment [4, 5] .
Recent cross-sectional and prospective studies have suggested that decreased kidney function is associated with cognitive impairment, cognitive decline and dementia in the general population, and diabetes mellitus [6] [7] [8] [9] [10] [11] . These authors explained that high risk of cardiovascular and cerebrovascular diseases can increase risk cognitive impairment in patients with impaired kidney function [6] [7] [8] [9] [10] [11] . Additionally, many conditions such as anemia, hypoproteinemia, and oxidative stress, may link CKD with reduced cognitive function [12, 13] . Furthermore, accumulative evidence has also demonstrated that the association remains unchanged even after controlling for cardiovascular and cerebrovascular diseases, suggesting that reduced kidney function may be an independent risk factor for cognitive impairment, although their mechanism is still unclear. However, results from other studies have also provided compelling evidence [14] .
A common feature in these studies is the relatively young age of the participants. These risk factors for cognitive impairment may differ in the very elderly [3] . In fact, mortality in the elderly might also differ among different age groups, thus removing a correlation between CKD and cognitive impairment. For example, authors found that depression was not directly associated with cognitive impairment in Chinese nonagenarians and centenarians [15] . In addition, reduced kidney function and cognitive impairment are also common problems in hypertensive patients [5, 11] . The Hypertension in the Very Elderly Trial showed significant association between cognitive function/dementia and serum creatinine in hypertensive persons aged 80 or over [3, 16] . Few studies, however have explored the association between kidney function and cognitive impairment in untreated hypertensive patients aged 80 or over, which may further demonstrate the relationship between the two conditions. The current study was undertaken to determine the impact of chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) on cognitive impairment among untreated hypertensive persons aged 80 or over in China.
Materials and Methods

Study subjects
The study population was selected by the cluster sampling method according to the database supplied by the Hypertension and Ageing Project of Chengdu (HAPC). The HAPC was performed in Chengdu city in order to explore the association among chronic cardiovascular diseases in rural inhabitants. In September 2007, rural inhabitants of Chengdu aged 80 or over were invited to join the study by oral notification. Out of 8461 subjects, 1423 responded to the invitation and agreed to participate in the study. Trained personnel visited all study participants at their homes for data collection, biological specimen collection, and anthropometric measurements. The current study is a part of the HAPC, and its purpose is to assess the association between the kidney function and cognitive impairment in the 80-year-old population with untreated hypertension. All patients with untreated hypertension were selected in the population. Patients with untreated hypertension were defined as a subject with hypertension who had never received antihypertensive drugs, or had not taken appropriate medication for at least three months. The current study ultimately included 395 rural inhabitants with untreated hypertension. The study was approved by the ethic committee of the Third People's Hospital of Chengdu. Written informed consent was obtained from subjects enrolled. Estimation of kidney function Blood sample for measurement of serum creatinine was obtained at baseline after an overnight fast. Serum creatinine was measured on frozen serum at a central laboratory using the Kodak Ektachem 700 Analyzer (Biochemistry laboratory, The Third Hospital of Chengdu). Estimated glomerular filtration rate (eGFR) was assessed using the Chinese Modification of Diet in Renal Disease equation, which is based on baseline age, gender, and serum creatinine concentration [17] . CKD was defined according to categorical approach, which is based on "YES" (eGFR below 60 ml/min) or "NO" (eGFR above 60 ml/min).
Cognitive impairment testing
Chinese adapted MMSE (CMMSE) has been utilized as a dementia screening instrument for epidemiological studies, and minimally modified culturally and formally to keep it in line with the original [18] . The CMMSE was used to assess cognitive function. It categorizes subjects according to the following: cognitive impairment (scores of 0-18), mild cognitive impairment (scores of [19] [20] [21] [22] [23] [24] , and normal cognitive functions (scores of [25] [26] [27] [28] [29] [30] . The MMSE scores have been shown to be 80%-90% sensitive and 80%-100% specific for the diagnosis of cognitive impairment [19] . The scoring system was used to assess the cognitive function of elderly Chinese in rural districts and demonstrated similar sensitivity and specificity [20] .
Measurements of other covariates
Other covariates included sociodemographic characteristics (age, gender, education, live alone, and smoking), relevant medical history (heart disease, stroke and diabetes), score on ADL, anthropometric measurement (body mass index) and biochemistry indicators (hemoglobin, albumin, triacylglycerol, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol). Sociodemographic characteristics were collected on the basis of the prepared questionnaire for the sample. Sitting or recumbent position, right arm blood pressure (BP) was measured twice to the nearest 2 mmHg using a standard mercury sphygmomanometer (phases I and V of Korotkoff) by trained nurses or physicians. The mean value of two measurements was used to calculate systolic BP (SBP) and diastolic BP (DBP). Diagnosis of hypertension was confirmed according to the criteria of the Joint National Committee (JNC) VII [21] . Details of coexistent medical illnesses were collected from the subjects' report of diagnoses as indicated by their doctors and medical charts.
A specialist in internal medicine determined the documentation of diagnoses, and assessments/ measurements for completion of final diagnoses, including heart disease, stroke, and diabetes. The Activity of Daily Living (ADL) is a measure of dependency on others for physical needs and functional status [22] . It has 14 items which comprise two scales: the physical self-maintenance scale (PSMS) (range 0-24) and instrumental activities of daily life scale (IADL) (range 0-32).
PSMS assesses the following six items: bathing, dressing, toileting, grooming, physical ambulation, and feeding. IADL assesses the ability to use telephones and public transportation, to go shopping, to prepare food, and the ability to carry out other daily tasks such as housekeeping, laundry, handling own medications, and finances. The higher the score, the less capable the subject is at performing everyday tasks. Findings with these measures in elderly people, including reliability and validity data, have been published elsewhere [23] . Body mass index (kg/m 2 ) was calculated as body weight (kilograms) divided by height (meters squared). Blood samples were collected after an overnight fast, and analyzed for hemoglobin, albumin, triacylglycerol, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol by standard laboratory techniques.
Statistical analyses
Continuous data were expressed as mean ± standard deviation (SD). Categorical data were expressed as a percentage. Differences in baseline characteristics according to category of eGFR ( < 60, and > 60ml/ min per 1.73 m 2 ) were compared using unpaired Student's t tests for continuous data, and chi-square tests/Fisher's exact tests for categorical data. Multivariable logistic regression was used to determine the association (expressed as odds ratio [OR] and 95% confidence interval [CI] ) between kidney function and cognitive impairment. In the cross-sectional analysis, the predictor variable was CKD (categorical variable) or eGFR (continuous variable), and the outcome was cognitive impairment. In model 1, we controlled for age and gender; in model 2, these variables including stroke, diabetes, triacylglycerol, and ADL score, which are 
Results
395 participants were recruited into the cross-sectional study. Of these participants, 276 were female and had a mean age of 83.0 ± 2.6 (SD) years; 358 (90.7%) of all participants did not receive any formal education. The mean (SD) cognitive function score for the sample was 17.6 (6.0) and the prevalence of cognitive impairment was 71.1%. The mean (SD) eGFR value was 79.1(21.3) and CKD was present in 14.9% (n = 59) of the sample. Compared with participants without CKD, participants with CKD were older, had higher scores on ADL, and lower scores on MMSE (Table 1) . In unadjusted analyses, CKD was associated with a significant increased prevalence of cognitive impairment. The association remained significant after additional adjustment for demographic characteristics (model 1: OR 3.367; 95% CI, 1.339 to 8.466), and ADL scores, diabetes, stroke, and triglycerides (model 2: OR 2.764; 95% CI, 1.069 to 7.151). When eGFR as a predictor variable entered into the model, the result remained significant in the two models (model 1: OR 0.986; 95% CI, 0.974 to 0.997; model 2: OR 0.988; 95% CI, 0.977 to 0.999) after adjusting for the same confounding factors ( Table 2) .
Discussion
In the cross-sectional study of 395 untreated hypertensive persons aged 80 or over in China, we found an association between CKD/eGFR and cognitive impairment, which was independent of potential confounding factors including age, gender, stroke, diabetes, ADL scores, and triacylglycerol.
These findings support the findings observed by several published cross-sectional studies. In a single-center study, 160 subjects with CKD had worse performance on tests of executive function and verbal memory compared with published norms [24] . Furthermore, in the Reasons for Geographic and Racial Difference in Stroke (REGARDS Study), CKD was associated with an increased prevalence of cognitive impairment independent of confounding factors, and for subjects with a eGFR less than 60 mL/min/1.73m 2 , each 10 mL/min/1.73m 2 decrease was associated with an 11% increased prevalence of cognitive impairment [9] . Other retrospective studies confirmed and extended this relationship to those with mildly reduced eGFR as measured according to neurophysiological tests and comprehensive testing in a particular domain for cognitive function, suggesting that even small reductions in kidney function are associated with clinically significant consequences for cognitive function [7, 8] . Recently, several longitudinal studies [3, 16] , in particular a study from China [6] , have indicated that reduced kidney function is associated with cognitive decline and the relationship is independent of potential confounders, including urinary albumin excretion. Compared with the studies mentioned above, the current study only included hypertensive patients, and also confirmed the association between CKD and cognitive impairment in hypertensive patients, even after controlling blood pressure. This suggests that the treatment focusing on reduced kidney function should be considered among aged hypertensive patients with impaired cognition, although only a small percentage of patients with hypertension will develop CKD [25] . To the best of our knowledge, few studies have explored an association between CKD or eGFR and cognitive impairment in persons aged 80 or over. Therefore, our study also extends the findings of previous studies, because the average age of our study is older than that of any previous study. In addition, our study included untreated hypertensive patients rather than treated hypertensive patients [3] , which will remove possible confounds of antihypertensive drugs.
There are several mechanisms that might link CKD with cognitive impairment. First, many traditional risk factors for cognitive impairment, such as diabetes, hyperlipemia, heart disease, and stroke often co-existed with CKD, which may lead to cognitive impairment [26] [27] [28] . Second, CKD is associated with white matter hyperdensities and silent infarctions suggesting that subclinical cerebrovascular disease underlies the association of kidney function and cognition [29] . Third, other abnormalities in CKD patients including anemia, hypoproteinemia, sleep disturbance, depression, inflammation, and oxidative stress could have an important role in the development and progression of cognitive impairment in hypertension [26, 30] . However, many established risk factors for cognitive impairment in the younger old, such as hypertension, metabolic syndrome and hyperlipoidemia, may be less important in the oldest old [31, 32] . Authors speculated that persons who reach the age of 90 or over, despite having cardiovascular diseases, are survivors who are relatively less susceptible to cognitive impairment. In other words, long-lived subjects might have fewer risk factors for cerebrovascular disease than do normal (less long-lived) elderly persons. Our study included subjects aged below 90, thus this explanation may not be suitable for the relationship between CKD and cognitive impairment.
Our study provides increased evidence for the association between kidney function and cognition among hypertensive patients aged 80 or over. However, there are some limitations that deserve mention. First, our study is cross-sectional and thus does not allow us to determine causal directions between cognitive impairment and CKD. Second, kidney function was estimated by applying a creatinine-based equation (CMDRD), which may be inaccurate for evaluation of kidney function among the oldest old people, because it depends to some extent on muscle mass and nutritional status. This can lead to overestimation of kidney function in elderly people with malnutrition, as malnutrition often increases with ageing. Third, using an MMSE score of < 24 is considered to be less sensitive for mild cognitive impairment than other tests, including Modified MMSE and Cognitive Capacity Screening Examination, even though diagnosis of cognitive impairment using this cut-off has been shown to be 80-90% sensitive and 80-100% specific compared with DSMMD-IV. However, the type of variation would bias our results toward null findings; it is therefore possible that we underestimated the true relationship. Fourth, our study lacked adjustment for other potential confounders, such as inflammatory markers, malnutrition status, heredity, and other sociodemographic factors, which may explain these results.
Conclusion
In conclusion, both CKD and eGFR were associated with cognitive impairment among hypertensive patients aged 80 or over in China. It could imply that measures of kidney function should be included in the assessment of cognitive impairment risk factors in hypertensive patients. In addition, given the high prevalence of CKD and cognitive impairment in hypertensive patients aged 80 or over, future clinical trials to improve cognition should consider targeting this high-risk population.
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